LORI SCHAFFER: Open Payments
NPI 1184167090 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,661 in 117 payments from 28 companies in 2025. Trend: 2023 $1,704 · 2024 $2,282 · 2025 $2,661
Food & beverage: $2,661
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $403 |
| PFIZER INC. | 15 | $353 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $241 |
| ABBVIE INC. | 10 | $223 |
| AstraZeneca Pharmaceuticals LP | 10 | $205 |
| Alnylam Pharmaceuticals Inc. | 3 | $187 |
| Phathom Pharmaceuticals, Inc. | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Exact Sciences Corporation | 5 | $97 |
| GlaxoSmithKline, LLC. | 4 | $83 |
Products named: CAPLYTA, Ozempic, Wegovy, NURTEC ODT, REXULTI, AMVUTTRA, VYNDAQEL, UBRELVY.
Industry payments across PA — which companies pay providers there.
